Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients - Castelli, R; Gritti, G; Cannavo, A (Immunopharmacol Immunotoxicol, 2012)
et al.